Khanban, Hedyeh, et al. “In Vivo Administration of G9a Inhibitor A366 Decreases Osteogenic Potential of Bone Marrow-Derived Mesenchymal Stem Cells”. EXCLI Journal, vol. 18, June 2019, pp. 300-9, doi:10.17179/excli2019-1234.